Shenzhen-based Sequencing Leader XZD Genomics Expands with New High-Throughput Lab in Guangzhou International Bio Island, Joining AstraZeneca iCampus

At the opening and signing ceremony for入驻,Ms. Huang Dongya, Head of the Investment Promotion Department of Guangzhou International Bio Island Management Committee; Mr. Chen An, Director of Guangzhou International Bio Island Group; Ms. Tong Ling, Assistant General Manager of Bio Island Group and Head of the Training Center; Mr. Yuan Shuo, Deputy Director of Digital and Commercial Innovation Department at AstraZeneca China, and Head of Greater Bay Area International Life Science Innovation Park and Regional Innovation Center; Mr. Fei Jiajun, Co-founder and Chief Information Officer of SEQUANTA; Mr. Lin Wei, Marketing Director of GenoMind Biotech; Ms. Shu Xiaoli, Sales Director for Southern Greater China at Illumina; Mr. Wang Shunyao, Deputy Director of Medical Application Department, China Marketing Center at MGI Tech; Dr. Li Yuan, General Manager and Chief Technology Officer of SEQUANTAand other guests jointly attended and witnessed this important moment.Afterward, the guestsActively shared insights on the future development direction of the store, as well as business cooperation and expansion strategies.RespectivelyInsights and prospects.

After the ceremony, the guests visited AstraZeneca's Guangzhou Biomedical Diagnostics Innovation Center. They learned about integrated diagnosis and treatment solutions and comprehensive disease management solutions supported by various associations and societies, covering all aspects such as disease prevention, diagnosis, treatment, and rehabilitation. The aim is to provide patients with comprehensive health management services. The Guangzhou International Life Science Innovation Park looks forward to collaborating with more partners to jointly promote the development of the intelligent healthcare industry and offer higher-quality services to a wide range of patients.

Currently, SEQUANTA Flash Testing Bio Island Store has been successfully introduced.MGI-DNBSEQ T7、Illumina NovaSeq 6000、GeneMind SURFSeq 5000Such high-end sequencing platforms have achieved comprehensive coverage of multiple brands, throughputs, and application scenarios, aiming to meet the diverse needs of a wide range of customers in the local and surrounding areas, and will provide an ultimate library sequencing delivery experience for all customers.

Dr. Li Yuan, General Manager and Chief Technology Officer of SEQUANTA, stated：“SEQUANTA, a leading company in the field of high-throughput sequencing in China, has been committed to empowering biopharmaceutical enterprises and improving overall industry efficiency through its excellent sequencing technology and services. Its move into the Guangzhou International Life Science Innovation Park not only shortens the distance to end customers but also further enhances the flexibility and responsiveness of its services. In the future, SEQUANTA will actively promote the integrated development of multi-omics and drug research through cooperation with the Guangzhou International Life Science Innovation Park and Training Center.”

Self2022Since the beginning of the year, SEQUANTA has been strategically expanding across China with a fresh perspective, establishing operations in seven cities: Beijing, Shanghai, Guangzhou, Wuhan, Shenzhen, Chengdu, and Shenyang.10A laboratory, forming a scaled-up sequencing service network.SEQUANTA Flash Testing allows customers to obtain high-quality data in a flexible and cost-effective manner, enabling broader penetration and reach of more sequencing application scenarios.

A diversified sequencing platform can further enhance the functionality and selectivity of sequencing services, providing customers with richer data throughput and more flexible delivery times to meet different research needs.

SEQUANTA Flash Testing Division Contact Hotline:021-6882-0851, welcome to contact us~